Effect of levosimendan therapy on myocardial infarct size and left ventricular function after acute coronary occlusion

Abstract

Eight weeks of levosimendan therapy after recent LAD occlusion decreases the size of MI and leads to better preservation of LV function as well as reduced LV remodelling.